Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 69 | 45 | 89 | 549 | 411 |
| Cost of Goods | 17 | 3 | 1 | 79 | 49 |
| Gross Profit | 52 | 42 | 88 | 470 | 362 |
| Operating Expenses | 2,466 | 2,413 | 3,097 | 3,265 | 3,690 |
| Operating Income | -2,397 | -2,368 | -3,008 | -2,716 | -3,279 |
| Interest Expense | 127 | 65 | 30 | 0 | 0 |
| Other Income | 0 | 1 | 5 | -7 | 56 |
| Pre-tax Income | -2,524 | -2,432 | -3,033 | -2,723 | -3,223 |
| Income Tax | N/A | N/A | N/A | 18 | 54 |
| Net Income Continuous | -2,524 | -2,432 | -3,033 | -2,741 | -3,277 |
| Net Income Discontinuous | -41 | -299 | -189 | N/A | N/A |
| Minority Interests | -22 | -42 | -35 | -30 | -56 |
| Net Income | $-2,543 | $-2,689 | $-3,187 | $-2,711 | $-3,221 |
| EPS Basic Total Ops | -2.46 | -2.46 | -2.82 | -2.46 | -3.17 |
| EPS Basic Continuous Ops | -2.46 | -2.11 | -2.82 | -2.55 | -3.07 |
| EPS Basic Discontinuous Ops | -2.46 | -0.35 | 0.00 | N/A | N/A |
| EPS Diluted Total Ops | -2.46 | -2.46 | -2.82 | -2.46 | -3.17 |
| EPS Diluted Continuous Ops | -2.46 | -2.11 | -2.82 | -2.55 | -3.07 |
| EPS Diluted Discontinuous Ops | -2.46 | -0.35 | 0.00 | N/A | N/A |
| EBITDA(a) | $-1,987 | $-2,024 | $-2,701 | $-2,385 | $-3,005 |